Common mistakes in the clinical use of bone mineral density testing

E. Michael Lewiecki, Nancy E Lane

Research output: Contribution to journalArticle

28 Citations (Scopus)

Abstract

Bone mineral density (BMD) testing is used to diagnose osteoporosis, assess fracture risk and monitor changes in BMD over time. A variety of devices and technologies are used to measure BMD or other surrogate markers of bone strength. Measurements obtained with these devices are often reported according to different proprietary standards, and the comparability of values obtained with different instruments is often poor. In addition, there is a high degree of variability in the skills of the technologists performing the tests and the clinicians interpreting the results. Heterogeneity in the guidelines for using BMD measurements together with poor-quality BMD testing and reporting can result in inappropriate clinical decisions, causing unnecessary worry and expense for the patient and possible harm due to unnecessary treatment or treatment being withheld. This Review describes and discusses the mistakes commonly made in BMD testing, and emphasizes the importance of maintaining high-quality standards in order to optimize patient management.

Original languageEnglish (US)
Pages (from-to)667-674
Number of pages8
JournalNature Clinical Practice Rheumatology
Volume4
Issue number12
DOIs
StatePublished - 2008

Fingerprint

Bone Density
Patient Harm
Equipment and Supplies
Osteoporosis
Biomarkers
Guidelines
Technology
Bone and Bones
Therapeutics

ASJC Scopus subject areas

  • Rheumatology

Cite this

Common mistakes in the clinical use of bone mineral density testing. / Lewiecki, E. Michael; Lane, Nancy E.

In: Nature Clinical Practice Rheumatology, Vol. 4, No. 12, 2008, p. 667-674.

Research output: Contribution to journalArticle

@article{8956d561b7ad4743983f9871e83ff63f,
title = "Common mistakes in the clinical use of bone mineral density testing",
abstract = "Bone mineral density (BMD) testing is used to diagnose osteoporosis, assess fracture risk and monitor changes in BMD over time. A variety of devices and technologies are used to measure BMD or other surrogate markers of bone strength. Measurements obtained with these devices are often reported according to different proprietary standards, and the comparability of values obtained with different instruments is often poor. In addition, there is a high degree of variability in the skills of the technologists performing the tests and the clinicians interpreting the results. Heterogeneity in the guidelines for using BMD measurements together with poor-quality BMD testing and reporting can result in inappropriate clinical decisions, causing unnecessary worry and expense for the patient and possible harm due to unnecessary treatment or treatment being withheld. This Review describes and discusses the mistakes commonly made in BMD testing, and emphasizes the importance of maintaining high-quality standards in order to optimize patient management.",
author = "Lewiecki, {E. Michael} and Lane, {Nancy E}",
year = "2008",
doi = "10.1038/ncprheum0928",
language = "English (US)",
volume = "4",
pages = "667--674",
journal = "Nature reviews. Rheumatology",
issn = "1759-4790",
publisher = "Nature Publishing Group",
number = "12",

}

TY - JOUR

T1 - Common mistakes in the clinical use of bone mineral density testing

AU - Lewiecki, E. Michael

AU - Lane, Nancy E

PY - 2008

Y1 - 2008

N2 - Bone mineral density (BMD) testing is used to diagnose osteoporosis, assess fracture risk and monitor changes in BMD over time. A variety of devices and technologies are used to measure BMD or other surrogate markers of bone strength. Measurements obtained with these devices are often reported according to different proprietary standards, and the comparability of values obtained with different instruments is often poor. In addition, there is a high degree of variability in the skills of the technologists performing the tests and the clinicians interpreting the results. Heterogeneity in the guidelines for using BMD measurements together with poor-quality BMD testing and reporting can result in inappropriate clinical decisions, causing unnecessary worry and expense for the patient and possible harm due to unnecessary treatment or treatment being withheld. This Review describes and discusses the mistakes commonly made in BMD testing, and emphasizes the importance of maintaining high-quality standards in order to optimize patient management.

AB - Bone mineral density (BMD) testing is used to diagnose osteoporosis, assess fracture risk and monitor changes in BMD over time. A variety of devices and technologies are used to measure BMD or other surrogate markers of bone strength. Measurements obtained with these devices are often reported according to different proprietary standards, and the comparability of values obtained with different instruments is often poor. In addition, there is a high degree of variability in the skills of the technologists performing the tests and the clinicians interpreting the results. Heterogeneity in the guidelines for using BMD measurements together with poor-quality BMD testing and reporting can result in inappropriate clinical decisions, causing unnecessary worry and expense for the patient and possible harm due to unnecessary treatment or treatment being withheld. This Review describes and discusses the mistakes commonly made in BMD testing, and emphasizes the importance of maintaining high-quality standards in order to optimize patient management.

UR - http://www.scopus.com/inward/record.url?scp=57149116730&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=57149116730&partnerID=8YFLogxK

U2 - 10.1038/ncprheum0928

DO - 10.1038/ncprheum0928

M3 - Article

VL - 4

SP - 667

EP - 674

JO - Nature reviews. Rheumatology

JF - Nature reviews. Rheumatology

SN - 1759-4790

IS - 12

ER -